Effect of lemborexant on sleep parameters and architecture in adult and elderly participants with mild-to-severe obstructive sleep apnea
Sleep Medicine · 2025
DOI: 10.1016/j.sleep.2025.106757 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Sleep Medicine, 2025. Verfasst von Atul Khullar und 5 weiteren Autor:innen. Beteiligte Einrichtung: University of Alberta, Edmonton, Alberta, Canada; Northern Alberta Sleep Clinic, Edmonton, Alberta, Canada. Hauptthemen laut MEDLINE: Sleep Apnea, Obstructive, Pyridines, Pyrimidines, Orexin Receptor Antagonists. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Canadian Institutes of Health Research, Restless Legs Syndrome Foundation, Eisai Inc.
Abstract (Originalsprache)
OBJECTIVE: To evaluate sleep parameters and architecture in a post hoc analysis of participants with untreated obstructive sleep apnea (OSA) who received lemborexant (LEM) 10 mg (LEM10), a competitive dual orexin-receptor antagonist approved for the treatment of adults with insomnia. METHODS: Study E2006-A001-102 (Study 102; NCT03471871) and Study E2006-A001-113 (Study 113; NCT04647383) were multicenter, randomized, double-blind, placebo (PBO)-controlled, 2-period cross-over studies in participants with mild OSA (apnea-hypopnea index [AHI] ≥5 to
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Alberta, Edmonton, Alberta, Canada; Northern Alberta Sleep Clinic, Edmonton, Alberta, Canada.
- Department of Medicine, Division of Neurology, Sunnybrook Health Sciences Centre and University of Toronto, Toronto, Ontario, Canada; Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute, Sunnybrook He…
- Centre for Addiction & Mental Health, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.
- Eisai Inc., Nutley, NJ, USA. Electronic address: Margaret_Moline@eisai.com.
- Eisai Inc., Nutley, NJ, USA.
Förderung
- Canadian Institutes of Health Research
- Restless Legs Syndrome Foundation
- Eisai Inc
- McGill University
- ResMed
- Eisai
- Eisai Canada
Zitieren
APA
Khullar, A., Boulos, M. I., Mak, M. S. B., Moline, M., Cheng, J. Y., & Hall, N. (2025). Effect of lemborexant on sleep parameters and architecture in adult and elderly participants with mild-to-severe obstructive sleep apnea. Sleep Medicine. https://doi.org/10.1016/j.sleep.2025.106757
Vancouver
Khullar A, Boulos MI, Mak MSB, Moline M, Cheng JY, Hall N. Effect of lemborexant on sleep parameters and architecture in adult and elderly participants with mild-to-severe obstructive sleep apnea. Sleep Medicine. 2025. doi:10.1016/j.sleep.2025.106757
BibTeX
@article{Khullar2025,
author = {Khullar, Atul and Boulos, Mark I and Mak, Michael S B and Moline, Margaret and Cheng, Jocelyn Y and Hall, Nancy},
title = {Effect of lemborexant on sleep parameters and architecture in adult and elderly participants with mild-to-severe obstructive sleep apnea},
journal = {Sleep Medicine},
year = {2025},
doi = {10.1016/j.sleep.2025.106757}
}
EUVIMED